Home -> Law Blog Directory -> Intellectual Property Law Blogs -> TinytechIP
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Intellectual Property Law
: TinytechIPUS Patent 7655479 - Q-dot biomarker for cancer detection
This patent is from H. Lee Moffitt Cancer Center and teaches the use of photo-enhanced nanocrystals to assist in the early detection of ovarian or lung cancer. Claim 1 reads:
1. A luminescent, bio-conjugate for use in the detection of cancerous and precancerous biomarkers in a sample, comprising:
wherein the nanoparticle is photo-enhanced with electromagnetic energy at between 325 nm and 488 nm, thereby generating electron-hole carrier pairs; and
at least one antibody associated with at least one cancer to be detected.
Full post as published by TinytechIP on February 03, 2010 (boomark / email).
Zantac Patent
GlaxoSmithKline and Cypress Pharmaceutical settle patent infringement dispute.
Pittsburgh Cancer Center
Wanrs of Cell Phone and Cancer Risk
Soliris Patent
Alexion Pharmaceuticals Inc. agrees to pay the Oklahoma Medical Research Foundation a $10 million patent infringement settlement.
DRAM Patent
ProMOS Technologies and Mosel Vitelic pay MOSAID Technologies an undisclosed patent infringement settlement.
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
Breast Cancer Patient Awarded $8.1 Million in Discrimination Case
Sony
to Pay $18.5 Million For Patent Infringment

Patent Profile: Vermillion Announces Allowance of Ovarian Cancer Biomarker Application
Patent Profile: EXACT Sciences Announces Issuance of Colorectal Cancer Screening Patent
Patent Profile: OncoGenex Announces Issuance of Patent for Antisense Cancer Therapeutic
Breast Cancer Awareness - Click to give a free Mammogram








